Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for AML
NCT03597321Phase 2Active, not recruiting
- Sponsor
- Institut Paoli-Calmettes
- Start
- Sep 2020
- Primary completion
- May 2027
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donor lymphocyte infusion in acute myeloid leukemia (AML), sponsored by Institut Paoli-Calmettes. Started Sep 2020; status: active, not recruiting.
02
Drugs
donor lymphocyte infusion
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03597321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597321.